Bio-Gene Technology Limited logo

Bio-Gene Technology Limited (BGT)

Market Open
ASX ASX
7.65M Market Cap
- P/E Ratio
- Div Yield
4,095 Volume
0 Eps
Want to track BGT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BGT is not paying dividends to its shareholders.
The last earnings report, released on Feb 25, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0033%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

Bio-Gene Technology Limited (BGT) FAQ

On which exchange is it traded?

Bio-Gene Technology Limited is listed on ASX.

What is its stock symbol?

The ticker symbol is BGT.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 7.65M.

Has Bio-Gene Technology Limited ever had a stock split?

No, there has never been a stock split.

Bio-Gene Technology Limited Profile

Biotechnology Industry
Healthcare Sector
Mr. Timothy Owen Grogan B.Sc., LLB CEO
ASX Exchange
Q1506Q101 CUSIP
Australia Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Bio-Gene Technology Limited is an agtech development company based in Melbourne, Australia, that specializes in the development and commercialization of innovative insecticides and pesticides. These products are designed for a wide array of applications, including animal health, crop protection, public health, and consumer markets. Since its inception in 1995, Bio-Gene Technology Limited has been at the forefront of creating effective solutions that aim to tackle the challenges presented by pests and insect-related issues in various sectors. Through its dedication to research and development, the company has established significant partnerships and collaborations with renowned institutions like James Cook University, BASF, Grains Research and Development Corporation, and the Queensland Department of Agriculture and Fisheries. These partnerships focus on refining product development processes and testing the effectiveness of Bio-Gene's solutions in real-world applications.

Products and Services

  • Flavocide

    Flavocide represents one of Bio-Gene Technology Limited's primary products. It is a synthetically produced, nature-identical compound designed to offer a new mode of action in the control of insect pests. The product targets a range of insects, ensuring effectiveness in crop protection, animal health, and public health sectors. Flavocide's development has involved rigorous testing and collaborations to ensure it meets the stringent requirements for efficacy and safety. Bio-Gene's partnership with entities like BASF and Grains Research and Development Corporation notably highlights the company's commitment to developing Flavocide as a game-changing solution in grain storage pest management and beyond.

  • Qcide

    Qcide is another flagship product from Bio-Gene Technology Limited, which derives from a natural oil extracted from a specific cultivar of eucalyptus cloeziana. The product's natural basis does not only signify Bio-Gene's commitment to eco-friendly solutions but also represents a strategic venture into the development of alternative pesticides that can serve a dual role of effectiveness and environmental safety. Through its collaboration with James Cook University, the company aims to refine the extraction processes of Qcide, enhancing its efficacy and potential applications in consumer products, demonstrating Bio-Gene's innovative approach to leveraging natural resources for pest control solutions.

Contact Information

Address: 400 Collins Street
Phone: 61 3 9068 1062